Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: A subtype comparison from baseline data of 2 randomized, placebo-controlled trials

Journal of Clinical Psychiatry

Volumn 69, Issue 7, 2008, Pages 1057-1063

  Gao, Keming ^a,c   Verduin, Marcia L ^b   Kemp, David E ^a   Tolliver, Bryan K ^b   Ganocy, Stephen J ^a   Elhaj, Omar ^a   Bilali, Sarah ^a   Brady, Kathleen T ^b   Findling, Robert L ^a   Calabrese, Joseph R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c 11400 Euclia Ave ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; PLACEBO; VALPROATE SEMISODIUM;

ADDICTION SEVERITY INDEX; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; GLOBAL ASSESSMENT SCALE; HOSPITALIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOME STUDY 36 ITEM SHORT FORM HEALTH SURVEY; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PANIC; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RAPID CYCLING BIPOLAR DISORDER; RETROSPECTIVE STUDY; SCORING SYSTEM; SEXUAL ABUSE; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; SUICIDE ATTEMPT; TREATMENT DURATION; VERBAL HOSTILITY;

EID: 47749134153     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0703     Document Type: Article

References (44)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-537
3. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003;60:261-269
4. Amsterdam JD, Shults J, Brunswick DJ, et al. Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression-low manic switch rate. Bipolar Disord 2004;6:75-81
5. Altshuler LL, Suppes T, Black DO, et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am J Psychiatry 2006;163:313-315
6. Tondo L, Baldessarini RJ, Hennen J, et al. Lithium maintenance treatment of depression and mania in bipolar I and II disorders. Am J Psychiatry 1998; 155:638-645
7. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518
8. Kessler RC, Rubinow DR, Holmes C, et al. Lhe epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med 1997;27:1079-1089
9. Grant BF, Stinson FS, Hasin DS, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and Axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005;66:1205-1215
10. Bauer MS, Altshuler L, Evans DR, et al. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord 2005;85: 301-315
11. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001;158:420-426
12. Suppes T, Leverich GS, Keck PE, et al. The Stanley Foundation Bipolar Treatment Outcome Network, 2: demographics and illness characteristics of the first 261 patients. J Affeet Disord 2001;67:45-59
13. Judd LL, Akiskal HS, Schcttlcr PJ, et al. The comparative clinical phenotype and longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorder? J Affect Disord 2003;73:19-32
14. Judd LL, Akiskal HS, Schettler PJ, et al. Psychosocial disability in the course of bipolar 1 and II disorders. Arch Gen Psychiatry 2005;62: 1322-1330
15. Maina G, Albert U, Bellodi L, et al. Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry 2007;68:207-212
16. Albert U, Rosso G, Maina G, et al. Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Affect Disord 2008; 105:297-303
17. Joffe RT, MacQueen GM, Marriott M, et al. A prospective, longitudinal study of percentage of time spent ill in patients with bipolar I or II disorders. Bipolar Disord 2004;6:62-66
18. Chengappa KNR, Levine J, Gershon S, et al. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disord 2000;2:191-195
19. Levander E, Frye MA, McElroy S, et al. Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. J Affect Disord 2007;101:211-217
20. Simon NM, Otto MW, Wisniewski SR. et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004;161:2222-2229
21. Sheehan DV, Lecrubier Y. Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
22. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Patient Version. Washington, DC: American Psychiatric Press; 1997
23. Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2003;53:1028-1042
24. McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. I Nerv Ment Dis 1980;168:26-33
25. Endicott J, Spitzer RL, Fleiss JL, et al. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-771
26. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36), 1: conceptual framework and item selection. Med Care 1992;30:473-483
27. Gao K, Ganocy SJ, Bilali S, et al. Pragmatic considerations in the comorbid presentations of anxiety disorder and substance use disorder in patients with rapid cycling bipolar disorder. In: New Research Program and Abstracts of the 159th Annual Meeting of the American Psychiatric Association; May 20-25, 2006; Toronto, Canada. Abstract NR 51:21
28. Frye MA, Altshuler LL, McElroy SL, et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry 2003;160:883-889
29. Mitchell JD, Brown ES, Rush AJ. Comorbid disorders in patients with bipolar disorder and concomitant substance dependence. J Affect Disord 2007;102:281-287
30. Back SE, Sonne SC, Killeen T, et al. Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse 2003;29:169-189
31. Parrott DJ, Drobes DJ, Saladin ME, et al. Perpetration of partner violence: effects of cocaine and alcohol dependence and posttraumatic stress disorder. Addict Behav 2003;28:1587-1602
32. Heil SH, Badger GJ, Higgins ST. Alcohol dependence among cocaine-dependent outpatients: demographics, drug use, treatment outcome and other characteristics. J Stud Alcohol 2001;62:14-22
33. Salloum IM, Douaihy A, Ndimbie OK, et al. Concurrent alcohol and cocaine dependence impact on physical health among psychiatric patients. J Addict Dis 2004;23:71-81
34. Bray JW, Zarkin GA, Dennis ML, et al. Symptoms of dependence, multiple substance use, and labor market outcomes. Am J Drug Alcohol Abuse 2000;26:77-95
35. MacKinnon DF, Zandi PP, Gershon ES, et al. Association of rapid mood switching with panic disorder and familial panic risk in familial bipolar disorder. Am J Psychiatry 2003; 160:1696-1698
36. MacKinnon DF, Zandi PP, Cooper J, et al. Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry 2002;159:30-35
37. Saunders EH, Scott LJ, McInnis MG, et al. Familiality and diagnostic patterns of subphenotypes in the National Institutes of Mental Health Bipolar sample. Am J Med Genet B Neuropsvchiatr Genet 2007;147B: 18-26
38. Rotondo A, Mazzanti C, Dell'Osso L, et al. Catechol O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder with and without comorbid panic disorder. Am J Psychiatry 2002;159:23-29
39. Simon NM, Otto MW, Fischmann D, et al. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. I Affect Disord 2005;87:101-105
40. Goodwin RD, Hoven CW. Bipolar-panic comorbidity in the general population: prevalence and associated morbidity. J Affect Disord 2002;70:27-33
41. Birmaher B, Kennah A, Brent D, et al. Is bipolar disorder specifically associated with panic disorder in youths? J Clin Psychiatry 2002;63: 414-419
42. Masi G, Perugi G, Millepiedi S, et al. Clinical and research implications of panic-bipolar comorbidity in children and adolescents. Psychiatry Res 2007;153:47-54
43. Frank E, Cyranowski JM, Rucci P, et al. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar disorder. Arch Gen Psychiatry 2002;59:905-911
44. Feske U, Frank E, Mallinger A, et al. Anxiety as a correlate of response to the acute treatment of bipolar disorder. Am J Psychiatry 2000; 157: 956-962